UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 5.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Meyer, S; Wild, P J; Vogt, T; Bataille, F; Ehret, C; Gantner, S; Landthaler, M; Klinkhammer-Schalke, M; Hofstaedter, F; Bosserhoff, A K (2010). Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Experimental Dermatology, 19(8):e251-e257.

Wild, P J; Fuchs, T; Stoehr, R; Zimmermann, D; Frigerio, S; Padberg, B; Steiner, I; Zwarthoff, E C; Burger, M; Denzinger, S; Hofstaedter, F; Kristiansen, G; Hermanns, T; Seifert, H H; Provenzano, M; Sulser, T; Roth, V; Buhmann, J M; Moch, H; Hartmann, A (2009). Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis. Cancer Epidemiology Biomarkers & Prevention, 18(6):1798-1806.

Sassen, A; Rochon, J; Wild, P; Hartmann, A; Hofstaedter, F; Schwarz, S; Brockhoff, G (2008). Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Research, 10:R2:1-13.

Burger, M; van der Aa, M N M; van Oers, J M M; Brinkmann, A; van der Kwast, T H; Steyerberg, E C; Stoehr, R; Kirkels, W J; Denzinger, S; Wild, P J; Wieland, W F; Hofstaedter, F; Hartmann, A; Zwarthoff, E C (2008). Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. European Urology, 54(4):835-844.

This list was generated on Fri Jul 21 15:55:17 2017 CEST.